These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32302946)

  • 41. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electroencephalography as a Non-Invasive Biomarker of Alzheimer's Disease: A Forgotten Candidate to Substitute CSF Molecules?
    Monllor P; Cervera-Ferri A; Lloret MA; Esteve D; Lopez B; Leon JL; Lloret A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis.
    Rossini PM; Miraglia F; Vecchio F
    Alzheimers Dement; 2022 Dec; 18(12):2699-2706. PubMed ID: 35388959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer's disease.
    Jackson CE; Snyder PJ
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S137-43. PubMed ID: 18631990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High PIB retention in Alzheimer's disease is an early event with complex relationship with CSF biomarkers and functional parameters.
    Forsberg A; Almkvist O; Engler H; Wall A; Långström B; Nordberg A
    Curr Alzheimer Res; 2010 Feb; 7(1):56-66. PubMed ID: 20205671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early diagnosis of Alzheimer's disease and mild cognitive impairment based on electroencephalography: From the perspective of event related potentials and deep learning.
    Wang C; Xu T; Yu W; Li T; Han H; Zhang M; Tao M
    Int J Psychophysiol; 2022 Dec; 182():182-189. PubMed ID: 36309183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sugihara causality analysis of scalp EEG for detection of early Alzheimer's disease.
    McBride JC; Zhao X; Munro NB; Jicha GA; Schmitt FA; Kryscio RJ; Smith CD; Jiang Y
    Neuroimage Clin; 2015; 7():258-65. PubMed ID: 25610788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tsallis entropy as a biomarker for detection of Alzheimer's disease.
    Al-Nuaimi AH; Jammeh E; Sun L; Ifeachor E
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():4166-9. PubMed ID: 26737212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological markers in Alzheimer's disease.
    Bailey P
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S72-6. PubMed ID: 17469687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early detection of Alzheimer's disease: new diagnostic criteria.
    Dubois B; Picard G; Sarazin M
    Dialogues Clin Neurosci; 2009; 11(2):135-9. PubMed ID: 19585949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resting state cortical EEG rhythms in Alzheimer's disease: toward EEG markers for clinical applications: a review.
    Vecchio F; Babiloni C; Lizio R; Fallani Fde V; Blinowska K; Verrienti G; Frisoni G; Rossini PM
    Suppl Clin Neurophysiol; 2013; 62():223-36. PubMed ID: 24053043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A machine learning approach to screen for preclinical Alzheimer's disease.
    Gaubert S; Houot M; Raimondo F; Ansart M; Corsi MC; Naccache L; Sitt JD; Habert MO; Dubois B; De Vico Fallani F; Durrleman S; Epelbaum S;
    Neurobiol Aging; 2021 Sep; 105():205-216. PubMed ID: 34102381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons.
    Babiloni C; Blinowska K; Bonanni L; Cichocki A; De Haan W; Del Percio C; Dubois B; Escudero J; Fernández A; Frisoni G; Guntekin B; Hajos M; Hampel H; Ifeachor E; Kilborn K; Kumar S; Johnsen K; Johannsson M; Jeong J; LeBeau F; Lizio R; Lopes da Silva F; Maestú F; McGeown WJ; McKeith I; Moretti DV; Nobili F; Olichney J; Onofrj M; Palop JJ; Rowan M; Stocchi F; Struzik ZM; Tanila H; Teipel S; Taylor JP; Weiergräber M; Yener G; Young-Pearse T; Drinkenburg WH; Randall F
    Neurobiol Aging; 2020 Jan; 85():58-73. PubMed ID: 31739167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer's disease patients.
    Scrascia F; Curcio G; Ursini F; Trotta L; Quintiliani L; Migliore S; Altamura C; Pitocco F; Altavilla R; Melgari JM; Quattrocchi CC; Vernieri F
    J Alzheimers Dis; 2014; 38(4):939-50. PubMed ID: 24121958
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease.
    Kouzuki M; Asaina F; Taniguchi M; Musha T; Urakami K
    Psychogeriatrics; 2013 Jun; 13(2):63-70. PubMed ID: 23909962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma Aβ42 as a Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
    Albani D; Marizzoni M; Ferrari C; Fusco F; Boeri L; Raimondi I; Jovicich J; Babiloni C; Soricelli A; Lizio R; Galluzzi S; Cavaliere L; Didic M; Schönknecht P; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Bocchio L; Salvatore M; Rossini PM; Tsolaki M; Visser PJ; Richardson JC; Wiltfang J; Bordet R; Blin O; Forloni G; Frisoni GB;
    J Alzheimers Dis; 2019; 69(1):37-48. PubMed ID: 30149449
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Leuzy A; Heurling K; Ashton NJ; Schöll M; Zimmer ER
    Yale J Biol Med; 2018 Sep; 91(3):291-300. PubMed ID: 30258316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Late life depression or prodromal Alzheimer's disease: Which tools for the differential diagnosis?].
    Gasser AI; Salamin V; Zumbach S
    Encephale; 2018 Feb; 44(1):52-58. PubMed ID: 28434642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.